Intervention to Improve Continuity of Care in Lung Cancer Patients
Evaluation of a Multi-faceted Intervention to Improve Continuity of Care for Patients With Lung Cancer
Sponsor: Canadian Cancer Society (CCS)
A NA clinical study on Lung Cancer, this trial is completed. The trial is conducted by Canadian Cancer Society (CCS) and has accumulated 7 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Cancer Society (CCS)
- Laval University
For direct contact, visit the study record on ClinicalTrials.gov .